Jubilant Pharmova has appointed Arun Kumar Sharma as its Chief Financial Officer (CFO) effective October 1, 2025. This appointment is for an interim period to ensure a smooth transition while the company identifies a permanent CFO. Sharma previously held various positions within the Jubilant Bhartia Group, including CFO roles at Jubilant Pharma Holdings Inc. USA and Jubilant Lifesciences Limited.
Interim CFO Announcement
Jubilant Pharmova Limited announced the appointment of Mr. Arun Kumar Sharma as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company, effective October 1, 2025.
Purpose of Appointment
The company clarified that this appointment is for an interim period. This is intended to facilitate a seamless transition to a new, permanent CFO. The process of identifying and appointing a suitable candidate for the full-time CFO position is currently underway.
Arun Kumar Sharma’s Profile
Mr. Sharma brings over three decades of experience in corporate finance, global treasury, investor relations, and risk management. He has a proven track record of driving growth and enhancing shareholder value. His prior roles within the Jubilant Bhartia Group include CFO positions at:
* Jubilant Pharma Holdings Inc. USA (approx. 4 years)
* Jubilant Lifesciences Limited (Chemical Business) (approx. 3 years)
* Jubilant Pharmova Limited (approx. 2 years, April 2021-May 2023)
Source: BSE
